Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis
NCT01486758Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Dec 2011
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in respiratory syncytial virus bronchiolitis comparing Azithromycin with Placebo (2 arms). Primary endpoints: Interleukin-8 Concentrations in Serum and Nasal Wash at Day 8 and Proportion of Participants with Recurrent (>=2) Wheezing Episodes. Started Dec 2011; status: completed.
02
Drugs
azithromycin
03
Conditions
respiratory syncytial virus bronchiolitis
Beyond the preview
Go deeper on NCT01486758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01486758.